18F-FDG PET/CT research progresses in assessing tumor burden of diffuse large B-cell lymphoma
10.13929/j.issn.1003-3289.2025.06.031
- VernacularTitle:18F-FDG PET/CT评估弥漫大B细胞淋巴瘤肿瘤负荷研究进展
- Author:
Hui GAO
1
;
Yang SUN
1
;
Yongyue ZHANG
1
;
Shumin WANG
1
Author Information
1. 北京大学第三医院超声医学科,北京 100191
- Publication Type:Journal Article
- Keywords:
lymphoma,large B-cell,diffuse;
tumor burden;
positron-emission tomography and computed tomography;
fluorodeoxyglucose F18
- From:
Chinese Journal of Medical Imaging Technology
2025;41(6):993-996
- CountryChina
- Language:Chinese
-
Abstract:
Diffuse large B-cell lymphoma(DLBCL)is the most common subtype of non-Hodgkin lymphoma,which demonstrates significant heterogeneity.Some DLBCL exhibit poor responses to chemotherapy,highlighting the urgent need for precise prognostic evaluation methods.As a critical biological parameter,tumor burden closely associated with disease progression and unfavorable prognosis,but representing tumor burden of DLBCL only with anatomical parameters was not enough to comprehensively reflect its biology features.Multiple parameters derived from 18F-FDG PET/CT could characterize metabolic features of tumors,hence enabling accurate quantification of tumor burden and providing a theoretical basis for individualized treatment of DLBCL.The research progresses of 18 F-FDG PET/CT for assessing tumor burden of DLBCL were reviewed in this article.
